Cargando…
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
BACKGROUND: Observational postmarketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine against HPV positivity of vaccine and nonvaccine types in a high-risk population. METHODS: We included all vaccine-eligible women f...
Autores principales: | Woestenberg, Petra J, King, Audrey J, van Benthem, Birgit H B, Donken, Robine, Leussink, Suzan, van der Klis, Fiona R M, de Melker, Hester E, van der Sande, Marianne A B, Hoebe, Christian J P A, Bogaards, Johannes A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853250/ https://www.ncbi.nlm.nih.gov/pubmed/29140439 http://dx.doi.org/10.1093/infdis/jix582 |
Ejemplares similares
-
Assessment of herd effects among women and heterosexual men after girls‐only HPV16/18 vaccination in the Netherlands: A repeated cross‐sectional study
por: Woestenberg, Petra J, et al.
Publicado: (2018) -
Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients
por: Woestenberg, Petra J, et al.
Publicado: (2020) -
Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019) -
An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
por: Donken, Robine, et al.
Publicado: (2016) -
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
por: Woestenberg, Petra J., et al.
Publicado: (2016)